Reporting owner · Q3 2026 · CIK 1222028

Kao John E: insider trades.

Kao John E reported 6 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($17.5M), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
6
Companies
1
Name as filed
KAO JOHN E

Companies

CompanyRelationshipTransactions
Alignment Healthcare, Inc. (ALHC)Director, Officer · Chief Executive Officer6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-14Alignment Healthcare, Inc.S27,400$13590,766Form 4
2026-09-11Alignment Healthcare, Inc.S385,270$12.681,223,473Form 4
2026-09-10Alignment Healthcare, Inc.S172,600$12.96618,166Form 4
2026-08-10Alignment Healthcare, Inc.S298,000$13.88790,766Form 4
2026-07-10Alignment Healthcare, Inc.S279,644$19.811,107,122Form 4
2026-07-10Alignment Healthcare, Inc.S18,356$20.651,088,766Form 4

Questions

What stock did Kao John E buy or sell?

Kao John E reported 6 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($17.5M), across 1 company.

Is Kao John E the same person as other filers with this name?

This page covers SEC CIK 1222028 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/kao-john-e-1222028.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.